Marker Therapeutics

-$0.0051 (-1.44%) As of 11:42 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRKR and other ETFs, options, and stocks.

About MRKR

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

CEO
Peter L. Hoang
Employees
56
Headquarters
Houston, Texas
Founded
1991

MRKR Key Statistics

Market cap
29.69M
Price-Earnings ratio
—
Dividend yield
—
Average volume
430.16K
High today
$0.363
Low today
$0.3259
Open price
$0.36
Volume
527.95K
52 Week high
$2.97
52 Week low
$0.25

MRKR Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure